Feasibility and safety of sequential research‐related tumor core biopsies in clinical trials
Jung Min Lee(Kyung Hee University), Elise C. Kohn(National Cancer Institute), Nicole Houston(Johns Hopkins University), Bradford J. Wood(National Institutes of Health), Christina M. Annunziata(National Cancer Institute), Lori M. Minasian(National Cancer Institute), Katherine R. Calvo(National Institutes of Health Clinical Center), Nilofer S. Azad(Johns Hopkins Hospital), Jennifer Squires(National Cancer Institute), John L. Hays(The Ohio State University), Minshu Yu(National Institutes of Health), Anne M. Noonan(The Ohio State University)
Cited by 33
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k